|
|
| | Quetmolimab Basic information |
| Product Name: | Quetmolimab | | Synonyms: | Quetmolimab;Research Grade Quetmolimab;Quetmolimab (anti-CX3CL1);E-6011|||KANAb 001 | | CAS: | 2084037-83-0 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Quetmolimab Structure]() |
| | Quetmolimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Quetmolimab Usage And Synthesis |
| Uses | Quetmolimab is a humanized anti-CX3CL1 monoclonal antibody. However, CX3CL1 is a chemokine with a modulating effect on chemotaxis and adhesion[1]. | | References | [1] Blaess J, et al. Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage. Ther Adv Musculoskelet Dis. 2020 Dec 16;12:1759720X20959971. DOI:10.1177/1759720X20959971 |
| | Quetmolimab Preparation Products And Raw materials |
|